Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 881

PDF Downloaded: 1245


Get Permission Roohi and Janaki: A study of maternal and perinatal outcomes in first and second waves of COVID-19


Introduction

In December 2019, pneumonia of unknown cause was first identified in the Wuhan, Hubei province of china, it led to the discovery of the novel corona virus. The virus was namedas severe acute respiratory syndrome corona virus 2(SARS-CoV-2) by World Health Organization. The virus went on to spread globally and the World Health Organization declared the outbreak as an emergency of international concern on 30 January 2020, and later declared it as a pandemic on 11 March 2020.1

As of September 26, 259,502,031clinically diagnosed and laboratory confirmed cases have been identified around the world.

Pregnant women are more susceptible to infectious diseases due to the immune suppression.1

Pregnancy is an immune condition that is unlike any other. The maternal immune system does not maintain a static immuno suppressed state, rather the immunological condition changes along with growth and development of the fetus. In the first trimester, maternal immune system is pro-inflammatory (favorable for implantation of embryo and placentation). In the second trimester, it is anti-inflammatory, (helpful for fetal growth), while in the third trimester, it is pro-inflammatory again, (in preparation for parturition).2

In a recent study, aghaeepour and colleagues suggested an immunological timing called immune-clock in the peripheral blood. They observed a pregnancy induced increase in signaling across multiple T-cell subsets, including CD25 naive and memory CD4 and CD8 cells.3

Systemic maternal viral infections have been shown to have an impact on pregnancy (Racicot et al., 2017).4 SARS infection during pregnancy has been linked to a high rate of spontaneous abortion, early birth, and intrauterine growth restriction in previous investigations (Wong et al., 2004).2

The majority of our second-wave theory is based on the 1918-20 "Spanish Flu," which infected 500 million people worldwide. The presence of waves were explained by increased transmission due to schools.5

Pathogenesis of SARS-CoV-2

SARS-CoV-2 is made up of 16 nonstructural proteins and 5-8 accessory proteins, as well as 4 structural proteins including spike (S), envelope (E) glycoprotein, nucleocapsid (N), and membrane (M) proteins.

The surface spike (S) glycoprotein helps the virus integrate into the host cell and is responsible for virus-cell membrane fusion. A receptor-binding domain (RBD) is a critical peptide domain in the pathogenesis of infection.

The development of SARS-CoV-2-induced pneumonia can be divided into two stages: early and late. Direct virus-mediated tissue damage forms the early phase. In late phase, the infected host cells trigger an immune response with the recruitment of multiple mediators causing release of high amounts of cytokines into the circulation, particularly IL-6 and TNF-α, resulting in a local and systemic inflammatory response.6

Genetic mutations are the cause for most of the evolutionary changes in organisms. A mutation is a change in the sequence of nucleotides that constitutes an organism's genome.7

Analysis of several RNA virus genomes and replication pathways reveals that the natural selection process balances the eradication of existing viruses with the introduction or re-emergence of new viruses.8

SARS-CoV-2 Variants of Concern (VOCs)

VOC’s includeAlpha (B.1.1.7 lineage), Beta (B.1.351 lineage), Gamma (P.1 lineage/GR/501Y), Delta (B.1.617.2 lineage), Epsilon (B.1.427 and B.1.429), Zeta (P.2), Eta and Iota, Theta (P.3), Kappa (B.1.617.1), Lambda (C.37) and Omicron(B.1.1.529).8, 9

Materials and Methods

This is a prospective analytical study done in the hospital, being a nodal centre for our entire state also being the only recognized centre by the government for management of covid -19 in the first wave. The hospital is located at the centre of city and conducts deliveries of approximately 10,000 patients every year.

A total of 1300 patients were included in the study, out of whom 800 were admitted during the first wave of the pandemic between April 2020 and February 2021 and the other 500 patients were admitted during the second wave of the pandemic between March 2021 and August 2021

Inclusion criteria

  1. All pregnant women who tested positive for COVID 19 and were admitted at our tertiary care hospital.

  2. All Women undergoing vaginal/ cesarean delivery at our hospital.

  3. All women undergoing abortion/ admitted for management of ectopic pregnancy in our hospital

  4. All women with covid positive statuses who delivered at other hospitals and were referred to our hospital for further management.

Exclusion criteria

  1. All women who tested negative for COVID 19.

  2. All women who left against medical advice or refused to reveal complete medical history or those with incomplete medical records.

Aims and Objectives of the Study were

  1. To assess the maternal morbidity and mortality due to covid-19 infection in the pregnant women.

  2. To assess the perinatal outcome in neonates of covid positive mothers.

  3. To compare the severity of covid infection between first and second waves of the pandemic.

Any medical or surgical illness and other relevant history along with demographic data like age, parity, gestational age, area of residence, history of contact, and history of travel were obtained at admission.

Monitoring was continued till delivery and indication for delivery, mode of delivery and condition of the neonate Apgar score and the treatment given to both mother and neonate were duly noted.

Evidence of perinatal transmission of virus was assessed by the SARS-associated corona virus reverse-transcriptase polymerase chain reaction (SARS-CoV RT-PCR)

Patients who required oxygen supplementation or mechanical ventilation were admitted to the maternal intensive care unit and closely monitored by a team of physician, obstetrician, anesthetist, ICU intensivist, and pulmonologists.

Rooming-in was recommended and neonatal swabs were sent within 24 hours.

The Institutional Ethics Committee (IEC) approval was taken for the study.

All the maternal and neonatal parameters were analyzed using descriptive statistics i.e. percentages and proportions were calculated. The Chi-square test was used to compare categorical variables in COVID positive mothers in the first and second wave of COVID-19. P value of less than 0.05 was considered significant.

Results

Table 1

Initial symptoms

No of women who developed the symptom in first wave(out if 800)

Percentage of women who developed the symptom in first wave

No of women who developed the symptom in second wave

Percentage of women who developed the symptom in second wave(out of 500)

P value

Fever

387

48.4%

77

15.4%

0.0001

Cough

244

30.5%

62

12.4%

0.0001

Running nose

65

8.1%

17

3.4%

0.08

Dyspnea

17

2.1%

13

2.6%

0.008

fatigue

60

7.0%

14

2.8%

0.06

Myalgia

54

6.7%

16

3.2%

0.06

Anosmia

327

40.9%

59

11.8%

0.08

Loss of taste

256

32%

43

8.6%

0.06

Sore throat

127

15.9%

15

3%

0.06

Diarrhea or vomiting

63

7.9%

53

10.6%

0.08

asymptomatic

313

39.1%

376

75.2%

0.98

Late symptom of dyspnea

87

10.9%

231

46.2%

0.001

A comparison of symptomatology of covid infection in the mothers admitted in the first wave shows that fever (48%) was the most common symptom followed by anosmia (40%), cough (30%) and sore throat (16%) while majority of the patients admitted in the second wave remained asymptomatic (75%) in the initial phase and later went on to develop shortness of breath (46%).

A Meta-analysis by Michael grant et al. also shows fever, cough and myalgia to be the major symptoms in their study of 24,410 adults with COVID 19 infection.10

Figure 1
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/0dd3d401-0cc9-47ea-88df-01d9317dcff7-uimage.png

Table 2

Baseline maternal characteristics

Median in first wave

Median in second wave

p- value

Median Age

23

25

0.082

Median gravidity

2

2

1

Median parity

1

1

1

Median BMI

25

29

0.0006

In the present study it was observed that there was no significant difference between maternal outcome in different age groups but that observation is limited as age variation among pregnant women in this study was minimal (mean age was 24 with standard deviation of 1 year).

There was no significant difference in maternal outcome with change in gravidity or parity of the pregnant mothers.

In the study, it was found that mothers who were overweight and obese had more severe illness as compared to mothers with normal weight or underweight.

This observation is comparable with the outcome found in a study done by Q cay et al on obesity and COVID 19 severity in a hospital Shenzhen, China. They found that obese individuals were at 3.4 times higher risk of developing severe covid illness.11

Table 3

Comparison of medical complications among first and second wave of COVID 19

Underlying conditions

No of women in the first wave having it(among 800)

Percentage of women in the first wave having it

No of women in the second wave having it(among 800)

Percentage of women in the second wave having it

p- value

Pre-eclampsia

104

13%

52

10.4%

0.0006

Eclampsia

22

4.4%

15

3%

0.009

Diabetes

97

12.1%

51

10.2%

0.04

Hypertension

27

3.4%

16

3.2%

0.01

Asthma

53

6.6%

24

4.8%

0.04

In our study, the incidence of pre-eclampsia was 13% during the first wave and 10.4% during the second wave. It was also found that presence of pre-eclampsia, eclampsia or other medical complications was associated with poor maternal outcomes both in first and second wave of COVID 19.

It is comparable to the multinational cohort study on maternal and neonatal mortality and morbidity done among pregnant women with covid, done by Jose Villardamong 2130 pregnant women where in presence of pre-eclampsia or other medical complications was found to be associated with increase maternal mortality and morbidity.12

Figure 2
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/ff7a0657-3db0-46c5-b109-5405ba144235-uimage.png

Table 4

Comparison of disease progression among pregnant women who died in first and second wave of COVID 19

In first wave(out of 800)

In second wave (out of 500)

Median GA, At diagnosis

36weeks

33weeks

Median GA, At delivery

38.5weeks

34.2weeks

Median Time, from symptoms to admission

1 day

10 days

Median time From admission to ICU(in severe cases)

12 days

1-2 hours

Median time From ICU to oxygen 5L O2

2-3 days

2 hours

Median time from 5L o2 to CPAP

3 days

10 hours

Median time CPAP to intubation

4 days

2 days

Median No of days intubation

12 days

10 days

Median No of days ICU stay

20 days

14 days

Median duration of Hospital stay

32 days

15 days

It was found that most of the mothers got admitted in the initial two days of developing symptoms during the first wave of covid, while in the second wave majority of the mothers remained asymptomatic initially and did not seek medical attention till the severity of the disease increased to develop shortness of breath. Median duration from onset of symptoms to hospitalization was 1 day in first wave and 10days in second wave.

It was also observed that disease progression from requirement of oxygen supplementation to requirement of invasive ventilation was gradual in first wave and very rapid in the second wave suggesting emergence of more virulent strains of the virus.

Figure 3
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/02e0a672-8987-408f-8fb2-ff719bb22659-uimage.png

Table 5

Comparison of maternal mortality and severity indicators in first and second wave of COVID 19

No of women in first wave(out of 800)

Percentage of women in first wave

No of women in second wave (out of 500)

Percentage of women in second wave

P value

Death

56

7%

72

14.4%

0.0013

Recovery after respiratory support

104

48%

83

34%

0.0017

High inflammatory markers

314

40%

302

60%

0.0001

High CT severity score

246

31%

237

47%

0.0019

Maternal complications

104

13%

95

19%

0.0035

Drug regimen Steroid

234

29%

228

46%

0.0001

Remedesvir

74

9%

114

23%

0.0073

It was found that there was significantly raised maternal mortality in second wave of covid compared to the first wave. Previous studies however, have shown no difference between mortality in first and second wave. 13

In this study high inflammatory markers and high CT severity scoring is found to be associated with higher maternal mortality and morbidity. Treatment with Remedesvir did not show any significant difference in maternal outcome.

Figure 4
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/1d4a8fae-b065-469e-ac51-2c64e462dd23-uimage.png

It is found that higher inflammatory markers were associated with increased incidence of still births and miscarriages, maternal respiratory distress and other maternal complications.

Table 6

Obstetric outcomes

No in first wave (out of 800)

Percentage in first wave

No in second wave (out of 500)

Percentage in second wave

P- value

Stillbirths

32

4%

24

6%

0.03

Miscarriages

28

3.5%

53

10.6%

0.001

Deliveries

686

413

Median days between SARS-CoV-2 diagnosis and delivery (IQR)

7 days

11 days

Figure 5
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/4b8169eb-2173-486f-a906-576d7d777471-uimage.png

In the present study it was found that incidence of abortions, still births, placental abruptions and preterm deliveries was higher in pregnant women infected with covid as compared to non-covid pregnant women. It was also found that the incidence of these conditions was significantly higher in the second wave of covid as compared to first wave.

Table 7

Mode of delivery

No in first wave(out of 800)

Percentage in first wave

No in second wave(out of 500)

Percentage in second wave

Vaginal

370

54%(among all deliveries)

178

43%(among all deliveries)

Cesarean delivery

315

46%(among all deliveries)

235

57%(among all deliveries)

In the present study the caesarean deliver rate is 46% in the first wave and 57%in the second wave. It was much lower in our study compared with other studies reaching as high as 93%.14

Cesarean delivery rate was higher in second wave compared to the first wave.

Figure 6
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/ee3d100a-394f-4e15-9efe-0a725725dbf0-uimage.png

Table 8

Neonatal characteristics

No in first wave

Percentage in first wave

No in second wave

Percentage in second wave

p- value

Gestational age at birth, weeks, median (IQR)

37 weeks

34 weeks

>37weeks

371

54%

107

26%

0.0001

<37 weeks

315

46%

306

74%

0.0004

Time from diagnosis to delivery

2 days

14 days

Birth weight z-score, median (IQR)

2.36Kgs

2.03Kgs

Birth-weight<10th percentile

151

22%

170

41%

0.0038

Apgar score <7 at 10 min

55

8%

120

29%

0.0001

Umbilical arterial pH, median (IQR)

7.38

7.26

Neonatal intubation

34

4.9%

84

20%

0.0013

NICU hospitalization

48

7.3%

92

24%

0.002

Neonatal death

14

2.1%

16

4%

0.0135

Neonate SARS-CoV-2–positive

34

5.3%

12

3.1%

0.0142

Figure 7
https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/2aeeea2c-e278-4e8c-aceb-dd4deae7a77b/image/812740b6-caac-4ce5-b88e-e41914b8672a-uimage.png

Apart from obstetric indications, maternal deterioration, failure to maintain adequate oxygenation or trouble with mechanical ventilation due to the gravid uterus, and fetal compromise were all reasons for an early delivery, more so, during the second wave.

Incidence of placental abruption and fetal distress as indication was also increased significantly between first and second wave.

Comparison of neonatal outcome between the first and second wave in the present study shows that there is increased incidence of preterm births among neonates born to covid positive mothers as compared to mothers not infected by covid. This can be explained by the presence of increased inflammatory process in mothers infected by covid.

Early induction of delivery or early caesarean sections done to rescue the mothers from respiratory distress was also another important reason for increased incidence of preterm births in second wave of covid.

There was also increased incidence of low birth weight, low Apgarscore, NICU admissions and neonatal deaths among neonates born to mothers infected by COVID-19 in the second wave as compared to the first wave.

The results are comparable to similar results found in a systematic reviews by Shin Qin Wei et al. and Danielle Di Mascio et al.15, 16

Conclusion

Among mothers hospitalised with COVID-19 infection at Gandhi hospital, higher rates of maternal respiratory distress, maternal ICU admissions, requirement of invasive ventilation, misscariiages, still births, preterm births, NICU admissions, maternal and neonatal deaths were reported during the second wave of infection as compared to the first wave. Above study findings can guide and enhance pre-natal counseling and management of pregnant women infected with COVID-19.

Source of Funding

None.

Conflict of Interest

The authors declare no conflict of interest.

References

1 

H Liu F Liu J Li T Zhang D Wang W Lan Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and childrenJ Infect2020805e7e13

2 

H Liu LL Wang SJ Zhao J Kwak-Kim G Mor AH Liao Why are pregnant women susceptible to COVID-19? An immunological viewpointJ Reprod Immunol202013910312210.1016/j.jri.2020.103122

3 

N Aghaeepour EA Ganio D Mcilwain AS Tsai M Tingle S Van Gassen An immune clock of human pregnancySci Immunol2017215eaan2946

4 

K Racicot G Mor Risks associated with viral infections during pregnancyJ Clin Invest2017127515919PMCID

5 

G Cacciapaglia C Cot F Sannino Multiwave pandemic dynamics explained: how to tame the next wave of infectious diseases Sci Rep20211116638

6 

Q Ye B Wang J Mao The pathogenesis and treatment of the `Cytokine Storm' in COVID-19J Infect202080660713PMCID

7 

N Kaur R Singh Z Dar RK Bijarnia N Dhingra T Kaur Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2Infect Genet Evol20218910449010.1016/j.meegid.2020.104490

8 

A Aleem ABA Samad AK Slenker Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19).In: StatPearls [Internet]StatPearls PublishingTreasure Island (FL)2022

9 

Classification of omicron (B.1.1.529): SARS-COV-2 variant of concern [Internet]. World Health Organization. World Health Organization; [cited 2021 Nov 30]https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

10 

MC Grant L Geoghegan M Arbyn Z Mohammed L Mcguinness EL Clarke The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countriesPLoS One2020156e0234765

11 

Q Cai F Chen T Wang F Luo X Liu Q Wu Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, ChinaDiabetes Care202043713928

12 

J Villar S Ariff RB Gunier R Thiruvengadam S Rauch A Kholin Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort StudyJAMA Pediatr20211758

13 

R Carbonell S Urgelés A Rodríguez M Bodí I Martín-Loeches J Solé-Violán COVID-19 SEMICYUC Working Group. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort studyLancet Reg Health Eur20211110024310.1016/j.lanepe.2021.100243

14 

W Arab D Atallah Cesarean section rates in the COVID-19 era: False alarms and the safety of the mother and childEur J Midwifery202151410.18332/ejm/134998

15 

SQ Wei M Bilodeau-Bertrand S Liu N Auger The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysisCMAJ202119316E5408

16 

Di Mascio D Khalil A Saccone G Rizzo G Buca D Liberati Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysisAm J Obstet Gynecol MFM20202210010710.1016/j.ajogmf.2020.100107



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

35-41


Authors Details

Aliya Roohi*, V Janaki


Article History

Received : 01-12-2021

Accepted : 31-12-2021


Article Metrics


View Article As

 


Downlaod Files